Retracted: Comparison of vildagliptin and glimepiride: effects on glycaemic control, fat tolerance and inflammatory markers in people with Type 2 diabetes

Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors

(2013) M. Barbieri et al.   ATHEROSCLEROSIS

Adipocytokine Levels in Obese and Non-obese Subjects: an Observational Study

(2013) Giuseppe Derosa et al.   INFLAMMATION

RETRACTED: Evaluation of the positive effects on insulin-resistance and β-cell measurements of vildagliptin in addition to metformin in type 2 diabetic patients

(2013) Giuseppe Derosa et al.   PHARMACOLOGICAL RESEARCH

Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease

(2012) Robert Klempfner et al.   Cardiovascular Diabetology

Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of dipeptidyl peptidase-IV inhibition

(2012) M. R. Rizzo et al.   DIABETES CARE

Dipeptidyl Peptidase-4 Inhibitors: 3 Years of Experience

(2012) Giuseppe Derosa et al.   Diabetes Technology & Therapeutics

Vildagliptin Added to Metformin on β-Cell Function After a Euglycemic Hyperinsulinemic and Hyperglycemic Clamp in Type 2 Diabetes Patients

(2012) Giuseppe Derosa et al.   Diabetes Technology & Therapeutics

Vildagliptin action on some adipocytokine levels in type 2 diabetic patients: a 12-month, placebo-controlled study

(2012) Giuseppe Derosa et al.   EXPERT OPINION ON PHARMACOTHERAPY

Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: Evaluation with euglycemic clamp and oral fat load

(2012) Giuseppe Derosa et al.   Journal of Clinical Lipidology

Are Sulfonylureas Less Desirable Than DPP-4 Inhibitors as Add-on to Metformin in the Treatment of Type 2 Diabetes?

(2011) Bo Ahrén   Current Diabetes Reports

Effects of n-3 PUFA on insulin resistance after an oral fat load

(2011) Giuseppe Derosa et al.   EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY

Pioglitazone Compared to Glibenclamide on Lipid Profile and Inflammation Markers in Type 2 Diabetic Patients During an Oral Fat Load

(2011) G. Derosa et al.   HORMONE AND METABOLIC RESEARCH

RETRACTED: Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study

(2011) Giuseppe Derosa et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study

(2010) D. R. Matthews et al.   DIABETES OBESITY & METABOLISM

Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load

(2010) Giuseppe Derosa et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Effects of One Year Treatment of Vildagliptin Added to Pioglitazone or Glimepiride in Poorly Controlled Type 2 Diabetic Patients

(2010) G. Derosa et al.   HORMONE AND METABOLIC RESEARCH

Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients

(2010) Giuseppe Derosa et al.   HYPERTENSION RESEARCH

Candesartan effect on inflammation in hypertension

(2010) Giuseppe Derosa et al.   HYPERTENSION RESEARCH

Effects of a standardized oral fat load on vascular remodelling markers in healthy subjects

(2010) Giuseppe Derosa et al.   MICROVASCULAR RESEARCH

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

(2009) E. Ferrannini et al.   DIABETES OBESITY & METABOLISM

Oral fat load effects on inflammation and endothelial stress markers in healthy subjects

(2009) Giuseppe Derosa et al.   HEART AND VESSELS

Dipeptidyl-Peptidase-IV Inhibition Augments Postprandial Lipid Mobilization and Oxidation in Type 2 Diabetic Patients

(2008) Michael Boschmann et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Measurements of Islet Function and Glucose Metabolism with the Dipeptidyl Peptidase 4 Inhibitor Vildagliptin in Patients with Type 2 Diabetes

(2007) Koichiro Azuma et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM